Synthesis, structure, and magnetic properties of the trans-difluoro-bis-phenoxo-bridged iron(III) complex FeIII2(BBPA)2F2 (H2BBPA = N,N-bis(2-hydroxybenzyl)-N-(2-pyridylmethyl)amine)
-
Add time:08/21/2019 Source:sciencedirect.com
The bis-phenoxo-bridged dinuclear iron(III) compound Fe2(BBPA)2F2 (H2BBPA = N,N-bis(2-hydroxybenzyl)-N-(2-pyridylmethyl)amine) was structurally and magnetically characterized. It has distorted octahedral iron(III) centers with each iron(III) site having two cis-Fe(BBPA)F fragments that are bridged by two μ-phenoxo oxygen atoms. The dinuclear compound has a singlet ground state and thermally populated S = 5 undecet excited state 114 cm−1 above the ground state as the magnetic susceptibility can be fit to the Van Vleck dimer equation (H = −2JSa·Sb) with g = 2.02, J/kB = −15 K (−10.4 cm−1), and a room temperature effective moment of 7.16 μB/FeIII2 in accord with weak antiferromagnetic coupling within the iron(III) dimer.
We also recommend Trading Suppliers and Manufacturers of N,N'-BIS(4-CHLOROPHENYL)-N,N'-DIPHENYL-1,4-PHENYLENEDIAMINE (cas 113703-66-5). Pls Click Website Link as below: cas 113703-66-5 suppliers
Prev:Imidazoline receptors: Qualitative structure-activity relationships and discovery of tracizoline and BENAZOLINE (cas 113698-36-5). Two ligands with high affinity and unprecedented selectivity☆
Next:Magnetic property and crystal structure of bis [N-(4-chlorophenyl) salicylideneaminato] oxovanadium (IV)) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- X-ray crystal structural and spectral studies of copper(II) and nickel(II) complexes of two asymmetric bis(thiosemicarbazone) ligands and the investigation of relationship between the N(4)-substituent and the electrochemical behavior08/25/2019
- Original articleN-Methylimidazolium perchlorate as a new ionic liquid for the synthesis of bis(pyrazol-5-ol)s under solvent-free conditions08/24/2019
- Nucleophilic alkynylation of N-bis(trimethylsilyl)methyl aldimines08/23/2019
- Magnetic property and crystal structure of bis [N-(4-chlorophenyl) salicylideneaminato] oxovanadium (IV)08/22/2019


